Abbott reports few adverse events in drug-coated stent study

05/21/2009 | CNNMoney

Abbott Laboratories said patients who received its Xience drug-eluting stent had few instances of repeat procedures or major cardiac events during a one-year study on more than 2,000 patients outside the U.S. The findings are similar to results from two clinical trials that helped Abbott secure marketing approval for the device in the U.S. and Europe.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD